Skip to main content

Table 3 Validation of Charlson comorbidity coding in the administrative database. Sensitivity, specificity, PPV and NPV with 95% CI of administrative data in identifying preoperative Charlson comorbidities, stratified by comorbidity type

From: Postoperative complications following colectomy for ulcerative colitis: A validation study

  n Sensitivity Specificity PPV NPV
Any Charlson comorbidity *      
  Totalα 193 0.37
[0.31–0.44]
0.98
[0.96–0.99]
0.90
[0.82–0.95]
0.75
[0.71–0.79]
  Active at Admissionβ 70 0.63
[0.51–0.73]
0.93
[0.90–0.95]
0.55
[0.44–0.65
0.95
[0.92– 0.96]
Any malignancy      
  Total 45 0.40 0.99 0.78 0.95
  Active 24 0.75 0.99 0.78 0.99
Cerebrovascular disease      
  Total 7 0.29 0.99 0.40 0.99
  Active 0 N/A 0.99 0.00 1.00
Chronic pulmonary disease      
  Total 70 0.21 1.00 0.88 0.90
  Active 7 0.29 0.97 0.12 0.99
Congestive heart failure      
  Total 13 0.31 0.99 0.50 0.98
  Active 0 N/A 0.99 0.00 1.00
Diabetes w/complication      
  Total 5 0.60 1.00 1.00 1.00
  Active 2 0.50 1.00 0.33 1.00
Diabetes w/o complication      
  Total 30 0.57 1.00 0.89 0.98
  Active 14 0.43 0.98 0.32 0.99
Hemiplegia/paraplegia      
  Total 2 0.00 1.00 0.00 1.00
  Active 1 0.00 1.00 0.00 1.00
  1. α Denotes total number of patients with the specified comorbidity. 193 patients presented with at least 1 Charlson comorbidity. However, sum of patients with each comorbidity type does not equal 193 as patients may have > 1 Charlson comorbidity.
  2. β Comorbidities stratified in chart review by activity on admission.
  3. * No patients identified with AIDS or dementia.